$MRK Headlines Health-care sector taking a bro
Post# of 72749
Posted On: 01/09/2015 10:08:03 AM
$MRK Headlines
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore
FDA clears Daiichi-Sankyo anticoagulant 7:55 p.m. Jan. 8, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 1:00 p.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Merck in 2015 10:44 a.m. Jan. 8, 2015 - 247WallSt.com
Trade-Ideas: Merck (MRK) Is Today's Momo Momentum Stock 9:49 a.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Johnson & Johnson in 2015 7:24 a.m. Jan. 8, 2015 - 247WallSt.com
5 Potential Blockbuster Drugs Set To Launch In 2015 7:02 a.m. Jan. 8, 2015 - Investors Business Daily
Meredith Acquires Selectable Media, Boosts Digital Portfolio - Analyst Blog 4:09 p.m. Jan. 7, 2015 - Zacks.com
The 4 Stocks That Lifted the DJIA on Wednesday 3:17 p.m. Jan. 7, 2015 - 247WallSt.com
CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog 2:16 p.m. Jan. 7, 2015 - Zacks.com
Pfizer: Seems Like The Right Time To Buy 1:51 p.m. Jan. 7, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 12:00 p.m. Jan. 7, 2015 - TheStreet.com
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers 5:39 p.m. Jan. 6, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Higher 2:00 p.m. Jan. 6, 2015 - TheStreet.com
3 Drugs Stocks On The Rise 12:10 p.m. Jan. 6, 2015 - TheStreet.com
5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List 8:10 a.m. Jan. 6, 2015 - 247WallSt.com
Dow Dividend Dogs: Yahoo Finds 2.83% Edge For 5 Lowest Price High Yield January 2 Issues 7:46 a.m. Jan. 6, 2015 - Seeking Alpha
J&J Starts Human Tests of Ebola Vaccine 6:57 a.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Dow Dividend Dogs: Arbitrage Finds .32% Advantage For 5 Lowest-Priced, High-Yield January 2 Issues 1:21 a.m. Jan. 6, 2015 - Seeking Alpha
A Dozen Dow Dividend Dogs Dance About 9% To 20% Upsides Into January 12:43 a.m. Jan. 6, 2015 - Seeking Alpha
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 22 min ago - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Today - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Today - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co. to buy Cubist Pharma in total deal valued at $9.5 billion 7:05 a.m. Dec. 8, 2014 - Carla Mozee
Merck's per-share bid for Cubist's stock is 37% above Friday's closing price 7:03 a.m. Dec. 8, 2014 - Tomi Kilgore
Merck & Co.: Cubist Pharma purchase is a 35% premium to shareholders 7:03 a.m. Dec. 8, 2014 - Carla Mozee
Merck to pay $102 a share for Cubist 7:02 a.m. Dec. 8, 2014 - Tomi Kilgore
FDA clears Daiichi-Sankyo anticoagulant 7:55 p.m. Jan. 8, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 1:00 p.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Merck in 2015 10:44 a.m. Jan. 8, 2015 - 247WallSt.com
Trade-Ideas: Merck (MRK) Is Today's Momo Momentum Stock 9:49 a.m. Jan. 8, 2015 - TheStreet.com
The Bullish and Bearish Case for Johnson & Johnson in 2015 7:24 a.m. Jan. 8, 2015 - 247WallSt.com
5 Potential Blockbuster Drugs Set To Launch In 2015 7:02 a.m. Jan. 8, 2015 - Investors Business Daily
Meredith Acquires Selectable Media, Boosts Digital Portfolio - Analyst Blog 4:09 p.m. Jan. 7, 2015 - Zacks.com
The 4 Stocks That Lifted the DJIA on Wednesday 3:17 p.m. Jan. 7, 2015 - 247WallSt.com
CytRx Jumps on Positive Results from Brain Cancer Study - Analyst Blog 2:16 p.m. Jan. 7, 2015 - Zacks.com
Pfizer: Seems Like The Right Time To Buy 1:51 p.m. Jan. 7, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Higher 12:00 p.m. Jan. 7, 2015 - TheStreet.com
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers 5:39 p.m. Jan. 6, 2015 - TheStreet.com
Dow Jones (DJIA) Today: Merck (MRK) Higher 2:00 p.m. Jan. 6, 2015 - TheStreet.com
3 Drugs Stocks On The Rise 12:10 p.m. Jan. 6, 2015 - TheStreet.com
5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List 8:10 a.m. Jan. 6, 2015 - 247WallSt.com
Dow Dividend Dogs: Yahoo Finds 2.83% Edge For 5 Lowest Price High Yield January 2 Issues 7:46 a.m. Jan. 6, 2015 - Seeking Alpha
J&J Starts Human Tests of Ebola Vaccine 6:57 a.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Dow Dividend Dogs: Arbitrage Finds .32% Advantage For 5 Lowest-Priced, High-Yield January 2 Issues 1:21 a.m. Jan. 6, 2015 - Seeking Alpha
A Dozen Dow Dividend Dogs Dance About 9% To 20% Upsides Into January 12:43 a.m. Jan. 6, 2015 - Seeking Alpha
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 22 min ago - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Today - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Today - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF
Harris & Harris Group Notes Publicly Traded Portfolio Company Enumeral Biomedical's Collaboration With Merck 12:29 p.m. Dec. 22, 2014 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Alnylam Announces Planned Departure of Chief Business Officer, Laurence Reid, Ph.D. 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
Merck Begins Tender Offer to Acquire Cubist 8:00 a.m. Dec. 19, 2014 - BusinessWire - BZX
(0)
(0)